Medical Campus aerial
Hepatology Program

The Hepatology Program at U-M Medical School is one of the largest and most well-established programs in the country. Established in 1954, the program has been advancing research, educating health care professionals and providing compassionate care to patients affected by all forms of liver disease for over 50 years.
For More Information
Program Overview

Headed by Anna Lok, MD, FRCP, past president of the American Association for the Study of Liver Diseases, the Hepatology Program includes over 20 faculty members and advanced practice providers with expertise in a wide variety of liver diseases.

Learn more about our program's leadership and history

Leading with excellence: The Division of Gastroenterology and Hepatology at the University of Michigan is the largest in the United States, with a large, dedicated team that takes a three-tiered approach to delivering care for liver disease.
About

Learn more about our program's history, our team members and our mission for providing state-of-the-art liver care.

Research

With a broad research portfolio, our program’s investigations span scientific, clinical and health services research.

Education

Our team is committed to the training of fellows in the GI Fellowship Program and Transplant Hepatology Fellowship Program.

Patient Care

Find clinic information, specialty clinics, procedure information and more.

Lectures & CME

During the year, we provide a variety of hepatology educational lectures and CME courses to U-M faculty as well as external health care providers.

See Opportunities
Featured News & Stories See all news 27th Annual Liver Disease Wrap-Up
Department News
27th Annual Liver Disease Wrap-Up
Join us for the 27th Annual Liver Disease Wrap-Up conference taking place on Saturday, December 7, 2024
 machine beige black
Health Lab
Histotripsy liver tumor trial successful, early clinical adoption recommended
The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. An expert explains more about it in this article.
 stethoscope listening to phone with doctor projected out of it
Health Lab
Could your phone detect hepatic encephalopathy by listening to you read?
Research suggests that one day a phone app could be able to detect the development of hepatic encephalopathy in patients just by listening to them speak.
 bacteria blue yellow
Health Lab
New guideline for Helicobacter pylori includes change to primary treatment recommendation
The American Journal of Gastroenterology has published a new guideline on the treatment of Helicobacter pylori (H. pylori) Infection. 
 Photo portrait of Ryan Stidham, MD
Department News
Appointment of Ryan Stidham, M.D., M.S., as DCMB Associate Chair for Clinical and Translational Research and as Associate Director of the Center for Computational Medicine and Bioinformatics (CCMB)
Ryan Stidham, MD, MS, from the Department of Internal Medicine, is appointed as DCMB Associate Chair for Clinical and Translational Research and as Associate Director of the Center for Computational Medicine and Bioinformatics (CCMB)
 hands holding syringe white
Health Lab
How do GLP-1 weight loss drugs affect the liver?
Glucagon-like peptide-1, or GLP-1, receptor agonists, that aid in weight loss, are now being investigated for their ability to help other patients, including those with liver disease. However, a research letter discusses the first known case of hepatitis and jaundice in a patient taking these drugs.
Stay Connected With Us